CN102715392A - Food with weight reducing function - Google Patents
Food with weight reducing function Download PDFInfo
- Publication number
- CN102715392A CN102715392A CN201210233735XA CN201210233735A CN102715392A CN 102715392 A CN102715392 A CN 102715392A CN 201210233735X A CN201210233735X A CN 201210233735XA CN 201210233735 A CN201210233735 A CN 201210233735A CN 102715392 A CN102715392 A CN 102715392A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- food
- kilograms
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 24
- 230000001603 reducing effect Effects 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 15
- 238000003672 processing method Methods 0.000 claims abstract description 6
- 239000007910 chewable tablet Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 7
- 239000002131 composite material Substances 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 229920002752 Konjac Polymers 0.000 abstract description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 7
- 229960001231 choline Drugs 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract description 6
- 235000012055 fruits and vegetables Nutrition 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract description 6
- 229960000367 inositol Drugs 0.000 abstract description 6
- 229930182817 methionine Natural products 0.000 abstract description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 abstract description 3
- 229960003237 betaine Drugs 0.000 abstract description 3
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 abstract 1
- 241001312219 Amorphophallus konjac Species 0.000 abstract 1
- 235000001206 Amorphophallus rivieri Nutrition 0.000 abstract 1
- 229920001661 Chitosan Polymers 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 229940108924 conjugated linoleic acid Drugs 0.000 abstract 1
- 239000000252 konjac Substances 0.000 abstract 1
- 235000010485 konjac Nutrition 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 22
- 208000020442 loss of weight Diseases 0.000 description 10
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 8
- 206010033307 Overweight Diseases 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 241000522254 Cassia Species 0.000 description 4
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 3
- 239000004380 Cholic acid Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 235000019416 cholic acid Nutrition 0.000 description 3
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 3
- 229960002471 cholic acid Drugs 0.000 description 3
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000004001 inositols Chemical class 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 102000040350 B family Human genes 0.000 description 2
- 108091072128 B family Proteins 0.000 description 2
- 206010019332 Heat exhaustion Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000036513 peripheral conductance Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 235000020004 porter Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000003161 proteinsynthetic effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a food with a weight reducing function. The food comprises the following components in part by weight: 30 to 35 parts of L-Carnitine- L-Tartrate, 3.5 to 8 parts of konjac powder, 3.5 to 8 parts of fruit and vegetable powder, 8 to 15 parts of milk sugar, 25 to 30 parts of glucose, 10 to 15 parts of sorbitol, 2 to 5 parts of conjugated linoleic acid, 1 to 3 parts of inositol, 1 to 3 parts of betaine, 0.5 to 1.5 parts of methionine, 1 to 3 parts of chitosan, 0.5 to 1.5 parts of choline and 0.5 to 1.5 parts of semen cassiae. The invention further discloses a processing method for preparing the food with the weight reducing function, the components of the food can not cause side effects to a human body, and an ideal weight reducing effect can be generated by taking the food in coordination with right exercises.
Description
Technical field
The present invention relates to functional food, especially relate to a kind of weight losing function food.
Background technology
Fat basic reason is that energy is taken in above energy consumption.The energy supply material of origin of heat in dietary intake: protein (4kcal/g), fat (9kcal/g), carbohydrate (4kcal/g), heat exhaustion is mainly by three aspects: basic metabolism, body movement and food fuel factor.Obesity causes owing to heat reaches positive balance (the heat intake is greater than the heat exhaustion amount).Overweight people's the death rate has significantly than normal type person and increases, and along with the increase of body weight, the death rate also increases to some extent.Research shows that the overweight people is 38.3% (male sex) and 37.2% (women) because of the dead person of diabetes obviously increases than the regular reorganization; Next is cirrhosis, appendicitis, cholelithiasis mortality in said patients, about the overweight people also doubles; The death rate of cardiovascular, ephrosis and contingency is also higher.It is higher than non-overweight people that the overweight people suffers from hypertensive probability.The overweight people often increases with cardiac output and blood volume, but normotensive overweight people, peripheral vascular resistance reduces, and the normal or rising of hypertensive overweight people's peripheral vascular resistance is arranged.Hypertension is the key factor of obesity high mortality.
Simultaneously, along with growth in the living standard, earth-shaking variation has also taken place in people's aesthetic standards, bony U.S.A also gradually become a kind of fashion, have sexy slender stature and also become each woman's pursuit of lifetime of liking to be beautiful.In order to reach the recognized standard stature, the personage that much likes to be beautiful begins to adopt extreme method of weight-reducing, goes on a diet insanely, moves insanely, has attempted the medicine of various fat-reducing, does not only reach the fat-reducing effect of expection at last, also messes around health on the contrary.A series of defect such as endocrine disturbance, resistance descend, in poor health, digestive discomfort also begin to occur.
Summary of the invention
To problem set forth above, the object of the invention is to provide a kind of fat-reducing effect well can not produce the weight losing function food of harm to health simultaneously.
The present invention realizes through following technical measures, and a kind of weight losing function food comprises the component of following each weight quota: L-carnitine tartrate 30～35; Konjaku powder 3.5～8; Fruits and vegetables powder 3.5～8; Lactose 8～15; Glucose 25～30; D-sorbite 10～15; CLA 2～5; Inositol 1～3; Betaine 1～3; Methionine 0.5～1.5; Shitosan 1～3; Choline 0.5～1.5; Cassia seed 0.5～1.5.
Concrete, weight losing function food comprises the component of following each weight quota: L-carnitine tartrate 30; Konjaku powder 5; Fruits and vegetables powder 5; Lactose 9; Glucose 27; D-sorbite 12; CLA 3; Inositol 2; Betaine 2; Methionine 1; Shitosan 2; Choline 1; Cassia seed 1.
Preferably, its formulation is chewable tablet or pulvis or granule.
The invention also discloses the processing method of this weight losing function food, procedure of processing comprises:
(1), will be less than or equal to the composite abundant mixing of 10 times of raw materials of 3 component like weight quota in claim 1 or 2 prescriptions, to guarantee the uniformity by required weight;
The required weight of weight and other each component that (2), will go up the composite mixture 1/10 of a step gained is mixed the back and is crossed behind 60 eye mesh screens subsequent use;
(3), the powder that will cross behind the screen cloth is dry under 60～75 ℃ temperature, stirs simultaneously each component is fully mixed, be dried to product moisture content (weight) and be lower than 5%;
(4), products obtained therefrom is carried out quantitative package bag packing or canned packing.
In the present invention, l-cn is a kind of essential coenzyme in the fat metabolism process, can promote aliphatic acid to get into mitochondria and carry out oxidation Decomposition.It scoops up in the fat entering Fuel Furnace like a forklift burns.If fat does not get into mitochondria, no matter how you take exercise, how to go on a diet, you can not consume it.And l-cn has just in time served as fat to mitochondrial " porter ".Fiber in the konjaku can promote gastrointestinal peristalsis, relaxes bowel, and prevents constipation and reduces the absorption of intestines to fat, help the treatment of enteric disorders, and can reduce the accumulation of body inner cholesterol, to prevent and treat hypertension, coronary sclerosis is significant; Konjaku is a low-heat food, and wherein contained glucomannan meeting imbibition can increase to 30～100 times of original volume, thereby after the food satiety arranged, and can be used for treating diabetes, also is desirable diet food.D-sorbite has excreta in the softening enteron aisle, the special efficacy of relief of constipation.CLA can be removed free radical, and the oxidation resistance of enhances human body and immunocompetence are regulated blood cholesterol levels and triglyceride level, prevent atherosclerotic, promotes fat oxidation to decompose, and promotes human body protein synthetic; It can also reduce the ratio of body fat tissue with respect to musculature effectively, really cuts fat, and lean body mass is increased, thereby improves human body intracellular metabolic level, so form benign cycle, fat-reducing will reach target more easily.Find clinically, the slimmer who takes CLA, the plan of losing weight that relatively can persevere is emotionally stable, sleep and mental status be good.Inositol can increase in the stimulating intestine and stomach activity, has promoted the digestion and the absorption of food, thereby has prevented flatulence and abdominal pain.In all B family vitamins, have only inositol can obviously increase gastral contraction.Inositol is with other a kind of B family vitamin---choline can constitute lecithin simultaneously.Lecithin can help digest food, and fat and the nutrients such as vitamin A, vitamin D, vitamin E and vitamin K that are dissolved in fat are absorbed and be transported in the blood, and its pair cell utilization fat also can play very crucial effect in addition.Shitosan has two mechanism to reduce cholesterol, and one is the absorption that stops fat, and another is that the cholesterol utilization in the blood of human body is fallen; At first, shitosan can suppress those activity that helps the lipase of fat absorption, is in addition to drain cholic acid, in case cholic acid is drained, then the cholesterol in the blood will be used to make cholic acid; These two kinds of mechanism make shitosan become the scavenger of strong cholesterol.Shitosan is a kind of natural material, has powerful anion absorption affinity, is applicable to reduce cholesterol and have no side effect.Cassia seed has the effect in ease constipation road; Cassia seed reduces the effect of serum total cholesterol and triglycerides in addition; Also have and reduce triglycerides and the effect that suppresses platelet aggregation in the rats'liver; Also there is report to point out that cassia seed does not have influence to the mice serum total cholesterol level of hypercholesterolemia, but can increases the ratio of serum high-density LP-cholesterol level and raising HDL-C/TC; Promptly obviously improve the distribution situation of body inner cholesterol, finally be transported to liver for cholesterol and do to handle at last very favourable.
The various components of the present invention can not have side effects to health, take product of the present invention simultaneously and cooperate suitable motion can produce desirable fat-reducing effect.
The specific embodiment
Do further explain below in conjunction with embodiment and to the present invention.
Embodiment 1
A kind of weight losing function chewable tablets, its composition of raw materials comprises:
A group: 30 kilograms of L-carnitine tartrates; 5 kilograms of konjaku powders; 5 kilograms in fruits and vegetables powder; 9 kilograms of lactose; 27 kilograms of glucose; 12 kilograms of D-sorbites;
B group: 30 kilograms of CLAs; 20 kilograms of inositols; 20 kilograms of betaines; 10 kilograms of methionine; 20 kilograms of shitosans; 10 kilograms in choline; 10 kilograms of cassia seeds.
The processing method of this weight losing function chewable tablets, procedure of processing comprises:
Its preparation method may further comprise the steps:
(1), with the composite abundant mixing of the raw material in the B assembly side, to guarantee the uniformity;
(2), 60 eye mesh screens are crossed in weight and each raw material mixing back of A group that will go up the composite mixture 1/10 of a step gained;
(3), the powder that will cross behind the screen cloth is dry under 60～75 ℃ temperature, stirs simultaneously each component is fully mixed, and is dried to product moisture content (weight) and is lower than 5%, is made into chewable tablets again;
(4), the gained chewable tablets is carried out quantitative package bag packing or canned packing.
Embodiment 2
A kind of weight losing function food, its composition of raw materials comprises:
A group: 30 kilograms of L-carnitine tartrates; 3.5 kilograms of konjaku powders; 3.5 kilograms in fruits and vegetables powder; 8 kilograms of lactose; 25 kilograms of glucose; 10 kilograms of D-sorbites;
B group: 20 kilograms of CLAs; 10 kilograms of inositols; 10 kilograms of betaines; 5 kilograms of methionine; 10 kilograms of shitosans; 5 kilograms in choline; 5 kilograms of cassia seeds.
Processing method and embodiment 1 are not in being pulvis with its formulation.
Embodiment 3
A kind of weight losing function electuary, its composition of raw materials comprises:
A group: 35 kilograms of L-carnitine tartrates; 8 kilograms of konjaku powders; 8 kilograms in fruits and vegetables powder; 15 kilograms of lactose; 30 kilograms of glucose; 15 kilograms of D-sorbites; 5 kilograms of CLAs;
B group: 30 kilograms of inositols; 30 kilograms of betaines; 15 kilograms of methionine; 30 kilograms of shitosans; 15 kilograms in choline; 15 kilograms of cassia seeds.
Processing method and embodiment 1 are not in being granule with its formulation.
The result of use survey report:
The time after discharge questionnaire that the weight losing function chewable tablets of being processed through 1000 clients of random choose embodiment 1 regularly quantitatively on probation did not wait in one month to three months; Reclaim 927 parts of questionnaires; Effectively questionnaire is 927 parts, with drawing following report behind 927 parts of questionnaire finishing analysis.
Table 1 loss of weight fat reducing effect:
| Effect | Number | Percentage |
| The success loss of weight | 880 | 95% |
| Other | 47 | 5% |
In 927 clients that eat the weight losing function chewable tablets, be successfully just have 880 clients " thin " by loss of weight up to 95% client; Remaining 5% client has selected other.And selected the client personnel of the client of other options according to us, the follow-up investigation learns these have selected the client of other options why not have loss of weight that reason is successfully arranged.
The time investigation that table 2 is edible:
| The edible time | 2-3 month | 1-2 month | 0-1 month |
| Number | 656 | 246 | 25 |
| Percentage | 70.8% | 26.5% | 2.7% |
One of unsuccessful reason of loss of weight: the edible time is short, shows according to survey data) show in 47 unsuccessful clients of fat-reducing, have 38% client to eat the weight losing function chewable tablets less than 1 month; Otherwise client's 99.5% loss of weight of edible weight losing function chewable tablets 2 months or 3 months is very successful; Being not difficult to find out that therefrom edible weight losing function chewable tablets loss of weight is not the thing on an one day at sunset, is to need to persevere.
The investigation of table 3 modest movement:
Unsuccessful another reason of loss of weight: combine the motion of appropriateness, show, in 47 unsuccessful clients of fat-reducing, do not move after 23% the edible weight losing function chewable tablets of client is arranged according to survey data; Otherwise the average halfhour client of every run duration behind the edible weight losing function chewable tablets, general selection the loss of weight success, wherein also have to comprise edible weight losing function chewable tablets 1-2 month client; The unsuccessful reason of 0.2% client's loss of weight remaining in these 927 clients is also uncertain.
More than be that weight losing function food of the present invention is set forth; Be used for helping to understand the present invention; But embodiment of the present invention is not restricted to the described embodiments; Any change that does not deviate under the principle of the invention to be done, modification, substitute, combination, simplify, all should be the substitute mode of equivalence, be included within protection scope of the present invention.
Claims (4)
1. weight losing function food is characterized in that comprising the component of following each weight quota:
2. weight losing function food according to claim 1 is characterized in that comprising the component of following each weight quota:
3. weight losing function food according to claim 1 and 2 is characterized in that: its formulation is chewable tablet or pulvis or granule.
4. the processing method of a weight losing function food is characterized in that procedure of processing comprises:
(1), will be less than or equal to the composite abundant mixing of 10 times of raw materials of 3 component like weight quota in claim 1 or 2 prescriptions, to guarantee the uniformity by required weight;
The required weight of weight and other each component that (2), will go up the composite mixture 1/10 of a step gained is mixed the back and is crossed behind 60 eye mesh screens subsequent use;
(3), the powder that will cross behind the screen cloth is dry under 60～75 ℃ temperature, stirs simultaneously each component is fully mixed, be dried to product moisture content (weight) and be lower than 5%;
(4), products obtained therefrom is carried out quantitative package bag packing or canned packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210233735XA CN102715392B (en) | 2012-07-06 | 2012-07-06 | Food with weight reducing function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210233735XA CN102715392B (en) | 2012-07-06 | 2012-07-06 | Food with weight reducing function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102715392A true CN102715392A (en) | 2012-10-10 |
| CN102715392B CN102715392B (en) | 2013-11-06 |
Family
ID=46941377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210233735XA Active CN102715392B (en) | 2012-07-06 | 2012-07-06 | Food with weight reducing function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102715392B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103054127A (en) * | 2012-12-12 | 2013-04-24 | 内蒙古伊利实业集团股份有限公司 | Cellulose effervescent tablet with weight reducing function |
| EP2875809A1 (en) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | Product based on an association of glucomannan and inositol |
| CN105341921A (en) * | 2015-11-21 | 2016-02-24 | 广州聚注专利研发有限公司 | Health food having healthy weight-losing effect |
| CN105707692A (en) * | 2016-01-28 | 2016-06-29 | 佛山市聚成生化技术研发有限公司 | Chinese yam noodles suitable for consumption of population recovering from dangerous illness and preparation method thereof |
| CN105707691A (en) * | 2016-01-28 | 2016-06-29 | 佛山市聚成生化技术研发有限公司 | Yellow peach noodles and preparation method thereof |
| CN106418526A (en) * | 2016-12-20 | 2017-02-22 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid type multifunctional food capable of reducing blood lipid and reducing weight |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151288A (en) * | 1995-11-29 | 1997-06-11 | 颜怀玮 | Nutrient for prevention and treatment of fatty liver caused by drinking wine and fat and its mfg. method |
| CN1406622A (en) * | 2001-09-11 | 2003-04-02 | 北京中科天鹤生物技术有限公司 | High efficiency weight reduction medicine or health-care food |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN102885900A (en) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | Composite with weight loss function and preparation method of composite |
-
2012
- 2012-07-06 CN CN201210233735XA patent/CN102715392B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1151288A (en) * | 1995-11-29 | 1997-06-11 | 颜怀玮 | Nutrient for prevention and treatment of fatty liver caused by drinking wine and fat and its mfg. method |
| CN1406622A (en) * | 2001-09-11 | 2003-04-02 | 北京中科天鹤生物技术有限公司 | High efficiency weight reduction medicine or health-care food |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN102885900A (en) * | 2012-10-10 | 2013-01-23 | 湖北省宏源药业有限公司 | Composite with weight loss function and preparation method of composite |
Non-Patent Citations (3)
| Title |
|---|
| 刘晓非等: "壳聚糖作为减肥药品的研究进展", 《高分子通报》, no. 02, 30 April 2005 (2005-04-30) * |
| 熊双丽: "功能性食品的发展及研究新动向", 《安徽农业科学》, no. 11, 20 April 2007 (2007-04-20) * |
| 钟国清: "甜菜碱及其应用", 《中国饲料》, no. 03, 31 December 1997 (1997-12-31) * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103054127A (en) * | 2012-12-12 | 2013-04-24 | 内蒙古伊利实业集团股份有限公司 | Cellulose effervescent tablet with weight reducing function |
| EP2875809A1 (en) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | Product based on an association of glucomannan and inositol |
| ITRM20130655A1 (en) * | 2013-11-26 | 2015-05-27 | Dicofarm Spa | PRODUCT BASED ON AN ASSOCIATION OF GLUCOMANNAN AND INOSITLE |
| CN105341921A (en) * | 2015-11-21 | 2016-02-24 | 广州聚注专利研发有限公司 | Health food having healthy weight-losing effect |
| CN105707692A (en) * | 2016-01-28 | 2016-06-29 | 佛山市聚成生化技术研发有限公司 | Chinese yam noodles suitable for consumption of population recovering from dangerous illness and preparation method thereof |
| CN105707691A (en) * | 2016-01-28 | 2016-06-29 | 佛山市聚成生化技术研发有限公司 | Yellow peach noodles and preparation method thereof |
| CN106418526A (en) * | 2016-12-20 | 2017-02-22 | 乌鲁木齐上善元生物科技有限公司 | Conjugated linoleic acid type multifunctional food capable of reducing blood lipid and reducing weight |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102715392B (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102742837B (en) | Health food used for improving symptom of malnutrition and preparation method thereof | |
| CN101869279B (en) | Edible mushroom black sesame powder and preparation method thereof | |
| CN107692240A (en) | A kind of high protein diet composition and its preparation method and application | |
| CN101317684B (en) | Solid beverage and preparation method there of | |
| CN102715392B (en) | Food with weight reducing function | |
| CN101473953A (en) | Fabricated food for cleaning blood and expelling toxin as well as method for processing the same and application | |
| CN102551044A (en) | Elderly nutrition powder prepared from wheat germ serving as main raw material | |
| CN102860461A (en) | Konjac composite nutritive rice | |
| CN102860468A (en) | Corn composite nutritive rice | |
| CN110301629A (en) | A kind of full nutrient solid beverage of tumor patient and preparation method thereof | |
| CN102599217A (en) | Health biscuits for lowering blood glucose and lipid | |
| CN102860469A (en) | Sweet potato composite nutritious rice | |
| CN1315418C (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN105146668A (en) | Deer blood polypeptide solid beverage | |
| CN101564180B (en) | Walnut total nutriment and soft capsule and health products containing same | |
| CN1864530A (en) | A refined health food of high and cold mountain area crop and processing technology thereof | |
| CN102871129A (en) | Yam composite nutrient rice | |
| CN105410930A (en) | Health-care product with weight-losing and body-slimming and nutrition-balancing functions and preparation method thereof | |
| CN108936601A (en) | A kind of health food and preparation method thereof preventing children anorexia, partial eclipse | |
| CN102613461B (en) | Rapidly beautifying and weight losing nourishment and preparation method thereof | |
| CN101646357A (en) | Nutritional supplements and method of producing the same | |
| CN103621883A (en) | Oatmeal for improving fatty liver and preparation method thereof | |
| CN1224339C (en) | Functional food and its use | |
| CN102669575A (en) | Healthcare enriched rice containing corn and preparation method thereof | |
| CN107822149A (en) | A kind of milk shake food for having fat reducing effect to human body and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170601 Address after: 518000 building E, 1980 Industrial Zone, people's street, Shenzhen District, Longhua District, Guangdong, 305-306 Patentee after: Shenzhen grace Century Technology Co., Ltd. Address before: 518000 Guangdong city of Shenzhen province Futian District Hailian building sky Pavilion 11C Patentee before: Zhang Wenbiao |
|
| TR01 | Transfer of patent right |